Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,3.5X18: medical device reports filed with FDA

306 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

306
device reports naming the brand
0% of all MAUDE reports · about 44 a year
61
reports, 12 months to August 2026
78 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 306 reports that name the brand "GM Helix Acqua Implant,Ti,3.5X18" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

61 reports arrived in the 12 months to August 2026, down 22% from 78 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (54.2%), loss of osseointegration (32.4%) and separation failure (0.7%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01019Sep 2021: 0Oct 2021: 4Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 1Mar 2022: 1Apr 2022: 2May 2022: 2Jun 2022: 1Jul 2022: 2Aug 2022: 2Sep 2022: 0Oct 2022: 1Nov 2022: 0Dec 2022: 12023Jan 2023: 0Feb 2023: 2Mar 2023: 16Apr 2023: 8May 2023: 8Jun 2023: 6Jul 2023: 6Aug 2023: 2Sep 2023: 5Oct 2023: 9Nov 2023: 2Dec 2023: 42024Jan 2024: 14Feb 2024: 2Mar 2024: 6Apr 2024: 12May 2024: 4Jun 2024: 3Jul 2024: 3Aug 2024: 11Sep 2024: 4Oct 2024: 10Nov 2024: 2Dec 2024: 62025Jan 2025: 0Feb 2025: 19Mar 2025: 13Apr 2025: 2May 2025: 0Jun 2025: 11Jul 2025: 2Aug 2025: 9Sep 2025: 3Oct 2025: 9Nov 2025: 5Dec 2025: 92026Jan 2026: 2Feb 2026: 3Mar 2026: 5Apr 2026: 2May 2026: 3Jun 2026: 5Jul 2026: 5Aug 2026: 10

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

041822019: 620192020: 1220202021: 1320212022: 1320222023: 6820232024: 7720242025: 8220252026: 352026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%306
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report61.8%189
Voluntary report0%0
User facility report0%0
Distributor report38.2%117
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate16654.2%62.8%
Loss of osseointegration9932.4%22.4%
Separation failure20.7%0.1%
Fracturea broken bone10.3%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis11035.9%
Painpain, site not specified9129.7%
Inflammationinflammation237.5%
Swelling/ edema92.9%
Fistula72.3%
Abscessa collection of pus62%
Hemorrhage/blood loss/bleeding62%
Sinus perforation41.3%
Tissue damage41.3%
Hyperresponsive to stimuli20.7%
Hypersensitivity/allergic reaction20.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,3.5X18Product code DZEAll MAUDE reports
Reports3063,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer61.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,3.5X18 reports

How many FDA reports name GM Helix Acqua Implant,Ti,3.5X18?

306 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 61 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (54.2%), loss of osseointegration (32.4%), separation failure (0.7%) and fracture (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (61.8%) and distributor reports (38.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,3.5X18 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.